Skip to main content
OpenTrials

Clinical trial condition

HIV-1-infection

Explore clinical trials studying HIV-1-infection. Study availability and eligibility vary by location and protocol.

230 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

HIV-1-infection trial results

Completed

A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV

NCT05630885

Conditions
Elevated Cardiovascular Risk, HIV-1-infection
Locations
  • University of California, Los Angeles CARE Center CRS (Site # 601) Los Angeles, California, United States
  • UCSD Antiviral Research Center CRS (Site # 701) San Diego, California, United States
  • UCSF HIV/AIDS CRS (Site # 801) San Francisco, California, United States
  • Harbor University of California Los Angeles Center CRS (Site # 603) Torrance, California, United States
View all 19 locations
View Trial Details
Completed

Study of Novel Antiretrovirals in Participants With HIV-1

NCT05585307

Conditions
HIV-1-infection
Locations
  • Long Beach Education and Research Consultants,Substudy-03 Long Beach, California, United States
  • Mills Clinical Research,Substudy-02 Los Angeles, California, United States
  • Mills Clinical Research,Substudy-03 Los Angeles, California, United States
  • Quest Clinical Research,Substudy-01 San Francisco, California, United States
View all 42 locations
View Trial Details
Completed

Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults

NCT04173819

Conditions
HIV-1-infection
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • The Rockefeller University New York, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • Partners in Health Research and Development Thika, Kiambu County, Kenya
View Trial Details
Completed

HIV-1 & Coronavirus-Coinfection in Europe: Morbidity & Risk Factors of COVID-19 in People Living With HIV

NCT05481216

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • CHU Saint Pierre Brussels, Belgium
  • Hôpital Européen Marseille Marseille, France
  • Hôpital Saint Louis Paris, France
  • Erasmus Medical Center Rotterdam, Netherlands
View all 23 locations
View Trial Details
Completed

Identification of Barriers and Facilitators of Implementation of the Out-of-Hospital Administration of the Long- Acting Combination Cabotegravir+Rilpivirina.

NCT06643897

Conditions
HIV-1-infection
Locations
  • Germans Trias I Pujol Hospital Badalona, Barcelona, Spain
  • CAP Dr Robert Barcelona, Spain
  • Centre de Salut Internacional i Malalties Transmissibles Drassanes - Vall d'Hebron Barcelona, Spain
  • BCN CheckPoint Barcelona, Spain
View Trial Details
Completed

Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTI Mutation K103N

NCT05349838

Conditions
HIV-1-infection
Locations
  • Institute of Tropical Medecine Antwerp, Belgium
  • St Pierre University Hospital Brussels, Belgium
  • CHU Hotel Dieu Nantes, France
  • Hospital Saint Louis Paris, France
View all 29 locations
View Trial Details

Related conditions